An interventional study of FlexiMitt in Very Low Birth Weight Infant, sponsored by Wyss Institute at Harvard University. Completed at 2 sites in United States. Open to participants aged 13 Months to 60 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-03.
Sponsored by Wyss Institute at Harvard University · Not applicable, Interventional, and Device feasibility
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Birth Weight with a site in United States — 6 open to participants now, 6 under way, none of them phase 3. Birth Weight · United States.
Among the 32 studies in Birth Weight with a site in United States, this one is the 12th largest by enrollment of the 19 interventional ones that give a count, is one of 4 that started in 2017, is one of 15 with no phase, and was the 18th registered.
185 studies on the registry are indexed under Birth Weight; 24 are open to participants now.
Browse Birth Weight studies →6 of the 32 studies in Birth Weight with a site in United States are open now. Recruiting first, the newest first:
University of Massachusetts, Worcester · Sites in United States
Ages 18+ · Women only
University of Tennessee · Sites in United States
Ages 1 min–6 hrs
Children's National Research Institute · Sites in United States
Ages up to 4 wk
Washington University School of Medicine · Sites in United States
Ages 14–55 · Women only · Healthy volunteers
The Hospital for Sick Children · Sites in United States, Canada
Ages 1 hrs–21 days
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 18 Birth Weight studies recruiting now, 7 (39%) set no upper age limit and 11 (61%) stop at 75 or younger; 11 take children under 18; 4 take healthy volunteers.
This study: 13 Months to 60 Months · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 1990; this study’s year is marked. 4 started in 2017.
This study's enrollment of 33 is below the median of 170 across 117 interventional studies indexed under Birth Weight.
Median enrollment 49 across the 19 interventional studies, 208 across the 13 observational. Of the 23 that completed or were terminated, 3 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 32 have an industry lead sponsor. The 10 most frequent:
Wyss Institute at Harvard University is the lead sponsor of 5 studies on the registry; none are open to participants now.
Wyss Institute at Harvard University has 1 study filed under Birth Weight — fewer than ten, so there is no comparison to draw.
1 of the studies in Birth Weight with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06870981The Hospital for Sick ChildrenOptimizing Nutrition and Milk (Opti-NuM) Project | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 32 studies in Birth Weight with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The morbidities associated with very low birth weight (VLBW) infants constitute a major health problem and a significant emotional and financial burden for families and our nation. The key to reducing this burden is early diagnosis. This research will be the first step towards intervention for cerebral growth and long-term neurodevelopmental morbidities of VLBW infants.
The proposed research is to design and fabricate a new technological innovation in wearable soft-sensors, called flexi-mitts, for measuring force modulation and joint angles of the hand (wrist and fingers) of toddlers. Building upon the investigators' ongoing work, they plan to engineer stretchable electronics for safe, toddler-scaled flexi-mitts to measure planning and force modulation.
The investigators' new flexi-mitt technology has the potential to provide a new diagnostic technology and the development of clinical assessment norms. With additional trials of the technology in large numbers of young children, it may be possible for clinicians and day care providers to eventually make measurements of planning and force modulation in play settings.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Children Born Prematurely ("Preterm") -
Pilot Studies:
Longitudinal Study:
Typically Developing Children ("Term") -
Pilot Studies:
Longitudinal Study:
Exclusion Criteria:
Both Preterm and Term
Term
Preterm
Term
Device: FlexiMitt
Preterm
Device: FlexiMitt
The proposed research designs and fabricates a new technological innovation in wearable soft-sensors, called flexi-mitts, for measuring force modulation and joint angles of the hand (wrist and fingers) of toddlers.
Design and Fabricate FlexiMitts
To measure joint angles and force
Time frame: Anticipated Year 1
Demonstrate Safety
Bench tests of material failure (i.e., stretch deformity and compositional integrity)
Time frame: Anticipated Year 1
Examine group differences between Groups 1 and 2
To examine group differences in force modulation and joint angles
Time frame: Anticipated Year 2 through 4
Examine longitudinal differences between Groups 1 and 2
To examine longitudinal changes in force modulation and joint angles at 24 and 30 months
Time frame: Anticipated Year 2 through 4
Ran from Aug 2017 to primary completion in May 2021, 45 months.
Of 43 non-industry interventional studies with no phase under Birth Weight, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 36. This study's 45 months is above that.
Counting every sponsor, half of 44 studies reached it within 19 months; a quarter within 15 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wyss Institute at Harvard University